Original Source(s)
Related Content
Combined Clavicle Model May Improve Age Estimates
Combined approach shows higher sensitivity than traditional thresholds for classifying legal adulthood.
April 22, 2026
-
3 min
FDA Expands Gene Therapy for Younger Patients
Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.
July 2, 2026
-
3 min
FDA Expands ASCENIV Pediatric Use
Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.
May 4, 2026
-
2 min